JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M607865200 on December 14, 2006

J. Biol. Chem., Vol. 282, Issue 12, 9195-9203, March 23, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/12/9195    most recent
M607865200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiffer, N. W.
Right arrow Articles by Schmid, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiffer, N. W.
Right arrow Articles by Schmid, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Anti-prion Compounds as Efficient Inhibitors of Polyglutamine Protein Aggregation in a Zebrafish Model*Formula

Niclas W. Schiffer{ddagger}, Sarah A. Broadley{ddagger}, Thomas Hirschberger§, Paul Tavan§, Hans A. Kretzschmar, Armin Giese, Christian Haass||, F. Ulrich Hartl{ddagger}1, and Bettina Schmid||2

From the {ddagger}Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried, Germany, the ||Adolf-Butenandt-Institute, Ludwig-Maximilians-University, Schillerstrasse 44, D-80336 Munich, Germany, the Center for Neuropathology and Prion Research, Ludwig-Maximilians-University, Feodor Lynen Strasse 23, D-81377 Munich, Germany, and the §Chair for BioMolecular Optics, Department of Physics, Ludwig-Maximilians-University, Oettingenstrasse 67, D-80538 Munich, Germany

Several neurodegenerative diseases, including Huntington disease (HD), are associated with aberrant folding and aggregation of polyglutamine (polyQ) expansion proteins. Here we established the zebrafish, Danio rerio, as a vertebrate HD model permitting the screening for chemical suppressors of polyQ aggregation and toxicity. Upon expression in zebrafish embryos, polyQ-expanded fragments of huntingtin (htt) accumulated in large SDS-insoluble inclusions, reproducing a key feature of HD pathology. Real time monitoring of inclusion formation in the living zebrafish indicated that inclusions grow by rapid incorporation of soluble htt species. Expression of mutant htt increased the frequency of embryos with abnormal morphology and the occurrence of apoptosis. Strikingly, apoptotic cells were largely devoid of visible aggregates, suggesting that soluble oligomeric precursors may instead be responsible for toxicity. As in nonvertebrate polyQ disease models, the molecular chaperones, Hsp40 and Hsp70, suppressed both polyQ aggregation and toxicity. Using the newly established zebrafish model, two compounds of the N'-benzylidene-benzohydrazide class directed against mammalian prion proved to be potent inhibitors of polyQ aggregation, consistent with a common structural mechanism of aggregation for prion and polyQ disease proteins.


Received for publication, August 16, 2006 , and in revised form, November 10, 2006.

* This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 596 A9 (to C. H. and B. S.), B6 (to F. U. H.), and B13 (to H. K. and A. G.); the Ernst Jung Foundation and Bundesministerium für Bildung und Forschung Grant 01KO0501 (to T. H., P. T., H. K., and A. G.); the Hereditary Disease Foundation's John J. Wasmuth fellowship (to S. A. B.); and the Hans & Ilse Breuer Foundation (to C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2, Table S1, and Video S1.

1 To whom correspondence may be addressed. Tel.: 49-89-8578-2233; Fax: 49-89-8578-2211; E-mail: uhartl{at}biochem.mpg.de.

2 To whom correspondence may be addressed. Tel.: 49-89-2180-75453; E-mail: Bettina.Schmid{at}med.uni-muenchen.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Kostka, T. Hogen, K. M. Danzer, J. Levin, M. Habeck, A. Wirth, R. Wagner, C. G. Glabe, S. Finger, U. Heinzelmann, et al.
Single Particle Characterization of Iron-induced Pore-forming {alpha}-Synuclein Oligomers
J. Biol. Chem., April 18, 2008; 283(16): 10992 - 11003.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Lemmens, A. Van Hoecke, N. Hersmus, V. Geelen, I. D'Hollander, V. Thijs, L. Van Den Bosch, P. Carmeliet, and W. Robberecht
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish
Hum. Mol. Genet., October 1, 2007; 16(19): 2359 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. L. Lumsden, T. L. Henshall, S. Dayan, M. T. Lardelli, and R. I. Richards
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Hum. Mol. Genet., August 15, 2007; 16(16): 1905 - 1920.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.